EXEL vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

EXEL

47.2
AI Score
VS
BBIO Wins

BBIO

55.7
AI Score

Investment Advisor Scores

EXEL

47score
Recommendation
HOLD

BBIO

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EXEL BBIO Winner
Revenue 610.81M 194.51M EXEL
Net Income 210.47M -166.56M EXEL
Net Margin 34.5% -85.6% EXEL
Operating Income 251.34M -105.96M EXEL
ROE 10.9% 7.3% EXEL
ROA 8.1% -12.1% EXEL
Total Assets 2.59B 1.37B EXEL
Cash 226.15M 879.89M BBIO
Current Ratio 3.26 1.52 EXEL
Free Cash Flow 250.34M -197.35M EXEL

Relative Price Performance (Last 90 Days)

EXEL 1M: -1.4% · 3M: +26.1% BBIO 1M: +3.6% · 3M: +16.6%

Current Technical Phase

EXEL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 51

RSI (14): 51.0 · Price: $55.06

BBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 50

RSI (14): 50.4 · Price: $79.96

Fundamentals Snapshot

Metric EXEL BBIO
Market Cap
Forward P/E 13.6 140.6
Trailing P/E 17.6
Revenue (TTM)
Revenue Growth 0.1% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% -0.5%
EPS 3.02 -3.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.